The current health crisis and the pharmaceutical industry’s subsequent efforts to develop new treatments and vaccines for
COVID-19 have brought the complexities of clinical research and development to the forefront of public attention. Vincenzo Salvatore and Vivian Grace Chammah at BonelliErede examine how artificial intelligence can be beneficial for clinical trials.